EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility

Serena Correnti, Mariaimmacolata Preianò, Annalisa Fregola, Fabia Gamboni, Daniel Stephenson, Rocco Savino, Angelo D'Alessandro, Rosa Terracciano

Frontiers in Pharmacology · 27.09.2023 · 14

DOI: 10.3389/fphar.2023.1275832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.09.2023. Verfasst von Serena Correnti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Magna Græcia University, Catanzaro, Italy. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male infertility occurs approximately in about 50% of all infertility cases and represents a serious concern worldwide. Traditional semen analysis alone is insufficient to diagnose male infertility. Over the past two decades, advances in omics technologies have led to the widespread application of metabolomics profiling as a valuable diagnostic tool for various diseases and disorders. Seminal plasma represents a rich and easily accessible source of metabolites surrounding spermatozoa, a milieu that provides several indispensable nutrients to sustain sperm motility and fertilization. Changes of metabolic profiles in seminal plasma reflect male reproductive tract disorders. Here, we performed seminal plasma metabolomics and lipidomics profiling to identify a new pattern of biomarkers of male infertility. Seminal plasma samples from unfertile subjects ( n = 31) and fertile controls ( n = 19) were analyzed using an untargeted metabolomics/lipidomics integrated approach, based on Ultra-High-Pressure Liquid Chromatography–tandem Mass Spectrometry. Partial Least Squares-Discriminant Analysis showed a distinct separation between healthy fertile men and infertile subjects. Among the 15 selected candidate biomarkers based on Variable Importance in Projection scores, phosphatidylethanolamine (PE) (18:1; 18:1) resulted with the highest score. In total, 40 molecular species showed statistically significant variations between fertile and infertile men. Heat-map and volcano plot analysis indicated that acylcarnitines, phosphatidylserine (PS) (40:2) and lactate were decreased, while PE (18:1; 18:1), Phosphatidic acid (PA) (O-19:2; 18:1), Lysophosphatidylethanolamine (LPE) (O-16:1) and Phosphatidylcholine (PC) (O-16:2; 18:1)-CH3 were increased in the infertile group. The present study is the first one to analyze the metabolomics/lipidomics dysregulation in seminal plasma between fertile and infertile individuals regardless of sub-infertility condition. Association of several metabolites/lipids dysregulation with male infertility reinforced data of previous studies performed with different approaches. In particular, we confirmed significantly decreased levels of PS and carnitines in infertile patients as well as the positive correlation with sperm motility and morphology. If validated on a larger prospective cohort, the metabolite biomarkers of infertility in seminal plasma we identified in the present study might inform novel strategies for diagnosis and interventions to overcome male infertility.

Schlagwörter

Stichwörter der Autor:innen

biomarkerslipidomicsmale infertiltymass spectrometrymetabolomicsreproductive medicineseminal plasma

Autor:innen und Institutionen

  • Department of Health Sciences, Magna Græcia University, Catanzaro, Italy.
  • Urogyn Biotech S. R. L., Catanzaro, Italy.
  • Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, Italy.
  • Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy.

Zitieren

APA

Correnti, S., Preianò, M., Fregola, A., Gamboni, F., Stephenson, D., Savino, R., D'Alessandro, A., & Terracciano, R. (2023). Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1275832

Vancouver

Correnti S, Preianò M, Fregola A, Gamboni F, Stephenson D, Savino R, et al. Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1275832

BibTeX
@article{Correnti2023,
  author = {Correnti, Serena and Preianò, Mariaimmacolata and Fregola, Annalisa and Gamboni, Fabia and Stephenson, Daniel and Savino, Rocco and D'Alessandro, Angelo and Terracciano, Rosa},
  title = {Seminal plasma untargeted metabolomic and lipidomic profiling for the identification of a novel panel of biomarkers and therapeutic targets related to male infertility},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1275832}
}
Kostenlos starten →